中国の卵巣がん治療薬市場

Asia Market Information & Developmentが発行した調査報告書(AMID-China-508048)
◆英語タイトル:Ovarian Cancer Treatment Drugs Markets in China
◆商品コード:AMID-China-508048
◆発行会社(リサーチ会社):Asia Market Information & Development
◆発行日:2015年7月
◆ページ数:244
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名使用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Global Site License(社内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAsia Market Information & Development社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Asia Market Information & Development社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、中国の卵巣がん治療薬市場について調査・分析し、中国のビジネス環境、産業構造、市場規模、市場成長要因、市場シェア、価格動向、外国からの投資、技術動向、生産及び需要動向、市場展望、マーケティング戦略、販売チャネル、製造メーカーリストなどの情報をお届けいたします。
【レポートの概要】

China’s demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China’s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2004, 2009 and 2014) and long-term forecasts through 2019 and 2024 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

【レポートの目次】

[TABLE OF CONTENTS]

I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT

Economic Outlook

Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade

Financial and Tax Regulations

Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Ovarian Cancer Treatment Drugs Industry Structure
Market Size
Market Growth Drivers
Ovarian Cancer Treatment Drugs Sales Volume
Major Producer Facility Locations
Major Producers’ Sales Volume and Market Share
Paclitaxel
Platinum Anticancer Drugs
Fluoropyrimidines
Anthracycline Antibiotics
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)
Anti-estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)
LH-RH
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investment
Technology Development

IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Overview

Ovarian Cancer Treatment Drugs Sales Volume

Chemotherapeutic Drug
Paclitaxel
Fluoropyrimidines
Anthracycline Antibiotics
Platinum Anticancer Drugs

Targeted Therapy Drug
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)

Endocrine Therapy Drug
Anti-estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)
LH-RH

Ovarian Cancer Treatment Drugs Import

Chemotherapeutic Drug
Anthracycline Antibiotics
Fluoropyrimidines
Paclitaxel
Platinum Anticancer Drugs

Targeted Therapy Drug
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)

Endocrine Therapy Drug
Anti-estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)
LH-RH

Pricing Trend

V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK

Ovarian Cancer Treatment Drugs Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

VI. MARKET ENTRY CHANNELS

China Market Entry Overview
China’s Distribution System
Ovarian Cancer Treatment Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications

China’s Market Entry
Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprises

VII. OVARIAN CANCER TREATMENT DRUGS PRODUCER DIRECTORY

Ovarian Cancer Treatment Drugs Producer Profiles and Directory

[LIST OF TABLES]

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification
Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification
Ovarian Cancer Treatment Drugs Sales Volume
Major Producer Facility Location
Major Ovarian Cancer Treatment Drugs Producer Sales Volume and Market Share
Major Foreign Investments in China

IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Ovarian Cancer Treatment Drugs Sales Volume
Chemotherapeutic Drug Major Producer and Their Market Share
Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification

Chemotherapeutic Drug Major Producer and Their Market Share
Paclitaxel Major Producer and Their Market Share
Fluoropyrimidines Major Producer and Their Market Share
Anthracycline Antibiotics Major Producer and Their Market Share
Platinum Anticancer Drugs Major Producer and Their Market Share
Targeted Therapy Drug Major Producer and Their Market Share
Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
Therapertic Antibody Major Producer and Their Market Share
Small Molecules Drug Major Producer and Their Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share
Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification
Endocrine Therapy Drug Major Producer and Their Market Share
Anti-estrogens Major Producer and Their Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share
LH-RH Major Producer and Their Market Share
Ovarian Cancer Treatment Drugs Import

V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK

Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

[LIST OF CHARTS]

I. INTRODUCTION

Ovarian Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports

III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Chemotherapeutic Drug Market Share by Drugs Classification
Targeted Therapy Drug Market Share by Drugs Classification
Endocrine Therapy Drug Market Share by Drugs Classification
Ovarian Cancer Treatment Drugs Sales Volume

IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Ovarian Cancer Treatment Drugs Sales Volume
Chemotherapeutic Drug Sales Volume and Market Share
Chemotherapeutic Drug Sales Volume by Drugs Classification
Paclitaxel Sales Volume and Market Share
Fluoropyrimidines Sales Volume and Market Share
Anthracycline Antibiotics Sales Volume and Market Share
Platinum Anticancer Drugs Sales Volume and Market Share
Targeted Therapy Drug Sales Volume and Market Share
Targeted Therapy Drug Sales Volume by Drugs Classification
Therapertic Antibody Sales Volume and Market Share
Small Molecules Drug Sales Volume and Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Sales Volume and Market Share

Endocrine Therapy Drug Sales Volume and Market Share
Endocrine Therapy Drug Sales Volume by Drugs Classification
Anti-estrogens Sales Volume and Market Share
Progesterone Sales Volume and Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Sales Volume and Market Share
LH-RH Sales Volume and Market Share
Ovarian Cancer Treatment Drugs Import
Chemotherapeutic Drug Import and Market Share
Chemotherapeutic Drug Import by Drugs Classification
Paclitaxel Import and Market Share
Anthracycline Antibiotics Import and Market Share
Fluoropyrimidines Import and Market Share
Placlitaxel Anticancer Drugs Import and Market Share
Platinum Anticancer Drugs Import and Market Share
Targeted Therapy Drug Import and Market Share
Targeted Therapy Drug Import by Drugs Classification
Therapertic Antibody Import and Market Share
Small Molecules Drug Import and Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Import and Market Share
Endocrine Therapy Drug Import and Market Share
Endocrine Therapy Drug Import by Drugs Classification
Anti-estrogens Import and Market Share
Progesterone Import and Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Import and Market Share
LH-RH Import and Market Share

VI. MARKETING STRATEGIES

China’s Distribution Channel



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 中国の卵巣がん治療薬市場(Ovarian Cancer Treatment Drugs Markets in China)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆